Here, we publish important new scientific research and materials, discuss significant NGP category developments in the media, report on scientific conferences we’ve attended, and more. Please note not all of this content is available in certain territories.
Behind the Headlines is a regular feature taking a slightly deeper dive into a piece of recent media coverage of NGP research. This edition’s story: In late February a number of outlets, including The Telegraph, reported vapers were “more likely to have gum disease”. The Daily Mail stated vape use “alters the mouth’s microbiome and […]
20 May 2020
Ahead of new legislation for the next generation of nicotine products in New Zealand, Strategic Science & Policy Engagement Director Grant O’Connell explains Imperial Brands’ stance on selling vapes. For the past five years, New Zealand smokers have been embracing the new generation of less harmful alternatives to conventional cigarettes. The number of adult smokers […]
13 May 2020
By Grant O’Connell, Strategic Science and Policy Engagement Director Beyond Smoke is an exciting new manifesto from Imperial Brands. It explains the scientific approach underpinning the development of our Next Generation Products (NGPs), and how our belief in the transformative potential of our NGP portfolio for adult smokers across the globe is grounded in the […]
24 Apr 2020
By Joe Thompson, Group Science and Regulatory Affairs Director 2019 was awash with negative media stories about vaping and lung disease, particularly in the US. Accurate, timely and complete reporting around the US EVALI developments from the media has been sadly lacking. There now seems to be consensus from the regulatory authorities in the US and […]
20 Apr 2020
By Alan Hardacre, Head of Group Corporate Affairs Many people – adult smokers and non-smokers alike – may well ask: ‘what is snus?’ Even though the oral tobacco product has been around for several centuries, it’s largely unknown, and misunderstood, outside of its native Scandinavia. The EU’s current ban on snus – with only Sweden […]
13 Mar 2020
Results of a new TT21C BioMAP assay show various NGPs, including myblu™, are potentially less toxic to cells compared to cigarette smoke By Arran Frood, Scientific Digital Communications Editor Last month, Imperial Brands released one of our most complex in-vitro assays completed to date. The study was presented at the Society for Research on Nicotine […]
3 Mar 2020
